Search results for negative tumors:
HPV-positive head and neck cancer patients fare better than HPV-negative patients
Medicine & Health / HIV & AIDS
Feb 12, 2008 |
5 / 5 (1) |
0
Head and neck cancer patients with HPV-positive tumors tend to survive longer and are more responsive to treatment compared with patients with HPV-negative tumors, according to a study published online February 12 in the ...
Five-year U.K. breast cancer trial starts
Jan 16, 2008 |
not rated yet |
0
Two British charities are joining to initiate the first U.K.-based clinical trial for women with a specific aggressive form of breast cancer.
ER/PR negative tumors associated with insurance status
Nov 18, 2008 |
5 / 5 (2) |
2
African-American women are at a higher risk for ER/PR negative breast cancer. A new study, to be presented at the American Association for Cancer Research's Seventh Annual International Conference on Frontiers in Cancer Prevention ...
Even tiny breast tumors can be aggressive and may require maximum therapy
Dec 16, 2007 |
5 / 5 (1) |
0
Breast tumors that are 1 centimeter in size or smaller — no more than 0.4 inch in length — can still be very aggressive and may require more intensive therapy than is routinely offered today, say researchers at Mayo Clinic ...
Adding tools against breast tumors
Oct 27, 2009 |
not rated yet |
0
At the end of a 10-year, coast-to-coast study of women with an unusual form of breast cancer, Richard J. Barth Jr., M.D., and three fellow researchers are making the case for a particular combination of treatments to stop ...
MRI 'best' for looking at breast cancer and more
Apr 11, 2008 |
5 / 5 (1) |
0
The use of MRI is effective in differentiating the blood supply to medial and lateral breast tumors, which is important in treatment planning and prognosis according to a study conducted by researchers at the University of ...
Study examines association between caffeine consumption and breast cancer risk
Oct 13, 2008 |
4 / 5 (2) |
0
Caffeine consumption does not appear to be associated with overall breast cancer risk, according to a report in the October 13 issue of Archives of Internal Medicine. However, there is a possibility of increased risk for wo ...
A new therapeutic option for human hepatocyte cancer
Sep 23, 2008 |
4 / 5 (1) |
0
p53-impaired tumors may be particularly suitable to parvovirus H-1-induced therapy. Although the p53 deficiency in tumors may induce resistance to chemotherapeutic agents, this will not affect the tumor cell susceptibility ...
Researcher finds most triple-negative breast cancers express muc-1 target
Dec 12, 2008 |
5 / 5 (1) |
1
Research out of the Ireland Cancer Center of University Hospitals Case Medical Center has found that the vast majority of triple negative breast cancers express the MUC-1 target. This first-of-its-kind finding, presented ...
Effect on breast tumors of DNA alternations in 3 genes described
May 16, 2007 |
5 / 5 (1) |
0
Cancer epidemiologists at the University at Buffalo have identified specific genes that are most likely to become cancer promoters when exposed to a process called DNA promoter hypermethylation.
'Triple negative' breast cancers linked to the young, minority
Mar 26, 2007 |
3.3 / 5 (3) |
0
So-called “triple negative” breast cancers, tumors that do not contain any of three significant tumor markers, are aggressive, deadly cancers that affect young, poor minority women, according to a new study.
Tamoxifen chemoprevention tied to early detection of breast cancer
Oct 07, 2008 |
4.5 / 5 (2) |
0
The drug tamoxifen does not prevent or treat estrogen receptor (ER) negative breast cancer, but it can make the disease easier to find, researchers report in the Oct. 1 Journal of the National Cancer Institute.
Study finds smoking related to subset of colorectal cancers
Apr 14, 2008 |
5 / 5 (2) |
0
Smoking puts older women at significant risk for loss of DNA repair proteins that are critical for defending against development of some colorectal cancers, according to research from a team led by Mayo Clinic scientists.
Researchers find breast cancer gene that's blocked by blood pressure drug
Jun 01, 2009 |
5 / 5 (1) |
1
Researchers have identified a gene that is overexpressed in up to 20 percent of breast cancers and that could be blocked in the lab by a currently available blood pressure drug, according to a new study from ...
Researchers develop new drug to target tumor cells and blood vessels
Apr 20, 2009 |
not rated yet |
0
Researchers at the University of Southern California have identified a new drug compound that appears to target tumor cells and surrounding blood vessels without the negative side effects typically associated with Cox-2 inhibitors.
